MANKIND

**Mankind Pharma Restructures BSVL Business**

**

:** The company has approved the **voluntary liquidation of Bharat Serums and Vaccines Ltd (BSVL)** as part of a restructuring exercise. Under the proposed arrangement, the BSVL business will be transferred to **Mankind Pharma**, allowing the operations to be consolidated directly within the parent company. **Appian Properties**, which holds a 4% stake in BSVL, will receive cash consideration for its stake. The transaction will not result in any change in Mankind Pharma’s existing shareholding pattern. Following completion of the voluntary liquidation process, BSVL will be dissolved. The restructuring is aimed at simplifying the group structure and integrating the BSVL business more closely with Mankind Pharma. **Stock Commentary:** **Positive;** the restructuring could simplify the corporate structure and allow Mankind Pharma to consolidate BSVL’s business and operations more directly. The cash settlement for Appian Properties and no change in Mankind Pharma’s shareholding pattern reduce potential ownership-related concerns. The move may also improve operational integration and provide better control over the acquired business. **Impact:** **Positive**